Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline
Public ClinicalTrials.gov record NCT01400425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01400425
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Avid Radiopharmaceuticals
- Industry
- Enrollment
- 239 participants
Conditions and interventions
Conditions
Interventions
- florbetapir F 18 Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2011
- Primary completion
- Jun 30, 2012
- Completion
- Jun 30, 2012
- Last update posted
- Mar 28, 2013
2011 – 2012
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85006 | — |
| Research Site | Sun City | Arizona | 85351 | — |
| Research Site | San Francisco | California | 94109 | — |
| Research Site | Boulder | Colorado | 80304 | — |
| Research Site | Boynton Beach | Florida | 33486 | — |
| Research Site | Clearwater | Florida | 33756 | — |
| Research Site | Fort Myers | Florida | 33912 | — |
| Research Site | West Palm Beach | Florida | 33407 | — |
| Research Site | Shreveport | Louisiana | 71130 | — |
| Research Site | Quincy | Massachusetts | 02169 | — |
| Research Site | Las Vegas | Nevada | 89121 | — |
| Research Site | New York | New York | 10021 | — |
| Research Site | Patchogue | New York | 11772 | — |
| Research Site | Durham | North Carolina | 27705 | — |
| Research Site | Greensboro | North Carolina | 27401 | — |
| Research Site | Providence | Rhode Island | 02903 | — |
| Research Site | Providence | Rhode Island | 02906 | — |
| Research Site | Houston | Texas | 77042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01400425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2013 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01400425 live on ClinicalTrials.gov.